Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Single Cell Sequencing Market Size is Worth USD 3,230.6 Million by 2027 | CAGR of 13.9%: Emergen Research

This image opens in the lightbox

News provided by

Emergen Research

28 Sep, 2020, 13:00 GMT

Share this article

Share toX

Share this article

Share toX

- Growing usage of Single Cell sequencing in oncology is one of the significant factors influencing the market growth.

- Market Size – USD 1,136.1 Million in 2019, Market Growth - CAGR of 13.9%, Market Trends –Growing occurrence of chronic diseases

VANCOUVER, BC, Sept. 28, 2020 /PRNewswire/ -- The Global Single Cell Sequencing Market is expected to reach USD 3,230.6 Million by 2027, according to a new report by Emergen Research. Single Cell sequencing finds widespread use in resolving heterogeneity of tumor, reconstruction of cancer cell evolutionary courses, and identification of rare sub-clones, thereby providing a promising technique for addressing resistance to drugs. Recently, researchers at the University of South California (USC) developed a method using Single Cell sequencing to identify sub-clones in cancer tissue that could provide important biological insights into how cancer progresses, how it spreads, and why it can become resistant to treatment.

Increased investment in R&D activities by the companies in the Single Cell sequencing industry is crucial in driving the growth of the market. For instance, 10X Genomics, a leading biotech firm engaged in the design and production of tech for genome sequencing, reported that its R&D expenditures rose to USD 22.2 million in the third quarter 0f 2019 from USD 11.1 million in 2018 during the same period, fueled by increased funding in workforce hiring, infrastructure development, and supplies.

Request free sample of this research report at: https://www.emergenresearch.com/request-sample/140

Key Highlights From The Report

  • Single Cell isolation aids in achieving cell viability of 99.0% without interfering with whole genome amplification, polymerase chain reaction (PCR), or whole transcriptome amplification (WTA) reactions and, therefore, held a substantial share of the market in 2019.
  • The next-generation sequencing (NGS) technology has drawn the attention of many companies and investors in various fields, including fundamental research, discovery, and production of pharmaceutical drugs, reproductive, and consumer genomics.
  • Instruments, in terms of revenue, held a larger market share in 2019, owing to the development and usage of advanced tools and solutions in the treatment of various chronic and infectious diseases.
  • Single Cell sequencing enables the categorization of cell types, as well as subtypes in the central nervous system at the transcriptome level, thereby aiding in solving issues associated with the complexity and heterogeneity of the nervous system and find out the brain formation mechanisms at various stages of developmental.
  • The Asia Pacific market is estimated to observe the fastest growth rate in the forecast period attributed to huge spending in R&D activities, along with sufficient strategic support and collaboration among the market players and research institutes.
  • In January 2020, Illumina made an announcement that scientists at Weizmann Institute of Science in Israel, a leader in Single Cell genomics, would use NGS technology by Illumina.
  • Key participants include Illumina, Thermo Fisher Scientific Inc., Fludigim, Bio-Rad, Becton, Dickinson, and Company, Qiagen, F Hoffmann-La Roche Ltd., BGI, 10X Genomics Inc., and Oxford Nanopore Technologies, among others.

To get leading market solutions, visit the link below: https://www.emergenresearch.com/industry-report/single-cell-sequencing-market

Emergen Research has segmented the global Single Cell sequencing market on the basis of product type, workflow, technology, disease type, application, end-use, and region:

Product Type Outlook (Revenue, USD Billion; 2017-2027)

  • Reagents
  • Instruments

Workflow Outlook (Revenue, USD Billion; 2017-2027)

  • Single Cell Isolation
  • Sample Preparation
  • Genomic Sequencing

Technology Outlook (Revenue, USD Billion; 2017-2027)

  • Sequencing
  • qPCR
  • Microarray
  • MDA
  • PCR

Disease Type Outlook (Revenue, USD Billion; 2017-2027)

  • Oncology
  • Immunology
  • Prenatal Diagnosis
  • Neurobiology
  • Microbiology
  • Others

Application Outlook (Revenue, USD Billion; 2017-2027)

  • Circulating Cells
  • Cell Differentiation/Reprogramming
  • Subpopulation Characterization
  • Genomic Variation
  • Others

End-Use Outlook (Revenue, USD Billion; 2017-2027)

  • Academic & Research Laboratories
  • Hospitals & Clinics
  • Biopharmaceutical & Biotechnology Companies
  • Others

Regional Outlook (Revenue, USD Billion; 2017-2027)

  • North America

1.  U.S.

2.  Canada

  • Europe

1.  Germany

2.  U.K.

3.  France

4.  Benelux

5.  Rest of Europe

  • Asia Pacific

1.  China

2.  Japan

3.  South Korea

4.  Rest of APAC

  • Latin America

1.  Brazil

2.  Rest of LATAM

  • Middle East & Africa

1.  Saudi Arabia

2.  UAE

3.  Rest of MEA

Find more similar research insights by Emergen Research:

In-Vitro Diagnostics Market By Product (Reagents & Kits, Instruments), By Technique (Immunoassay, Clinical Chemistry), By Devices (Reusable IVD Devices, Disposable IVD Devices), By Application (Cancer, Infectious Diseases), By End-Use, and By Region, Forecasts to 2027

Cancer Immunotherapy Market By Technology (Monoclonal Antibodies, Vaccines, Checkpoint Inhibitors), By Application (Head & Neck Cancer, Blood Cancers, Liver Cancer), By End-Use (Cancer Specialty Centers, Hospitals and Clinics), and By Region, Forecasts to 2027

Blockchain in Healthcare Market By Type (Permissioned/Private Blockchain, Permissionless/Public Blockchain), By Application, By End-Users (Pharmaceutical Companies, Healthcare Providers, Healthcare Payers), Forecasts to 2027

Advanced Wound Care Market By Product Type (Moist Wound Dressing, Wound Therapy Devices), By Wound Type (Surgical Wounds, Ulcers, Burns, Traumatic Wounds), By End-User (Hospitals and Clinics, Home Care Settings), and By Region, Forecasts to 2027

Cancer Tumor Profiling Market By Technique Type (Genomics, Epigenetics, Metabolomics, Proteomics), By Technology (Immunoassays, In Situ Hybridization, PCR), By Application (Research And Clinical Application), Forecasts to 2027

Craniomaxillofacial Devices Market Analysis, By Product (Cranial Flap Fixation Device, CMF Distraction Device, Drugs), By Material (Metal Based Implants, Bioabsorbable Material), By Application, By End-Use, Forecasts to 2027

About Emergen Research 

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

With market-leading insights and an in-depth understanding of leading and niche technologies, our solutions address the most pertinent questions for your business needs. A major technological shift has been witnessed towards creating a 'Circular Economy,' fuelled by factors, such as the increased adoption of bio-based materials, along with other methods for achieving carbon neutrality. We are conversant in technologies, viz., Artificial Intelligence (AI), Augmented Reality (AR), Virtual Reality (VR), Robotic Process Automation (RPA), Smart Manufacturing, Internet of Things (IoT), Big Data Analytics, Machine learning, Nanotechnology, Edge Computing, Blockchain Technology, Cloud Computing, Vehicle Electrification, Advanced Maintenance Analytics, and Predictive Maintenance, among other prevalent and emergent technologies.

Contact Us:

Eric Lee
Corporate Sales Specialist
Emergen Research | Web: https://www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com

Read full Press Release at : https://www.emergenresearch.com/press-release/global-Single Cell-sequencing-market

Logo: https://mma.prnewswire.com/media/1252126/Emergen_Research_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.